Skip to main content
. 2018 Jan 26;2018(1):CD012551. doi: 10.1002/14651858.CD012551.pub2

Comparison 17.

Sono‐electromagnetic therapy versus placebo

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Prostatitis symptoms (NIH‐CPSI total) 1 60 Mean Difference (IV, Fixed, 95% CI) ‐2.80 [‐6.75, 1.15]
2 Prostatitis symptoms 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 1.4 [0.91, 2.15]
3 Prostatitis symptoms: pain subscore 1 60 Mean Difference (IV, Fixed, 95% CI) ‐1.30 [‐3.44, 0.84]
4 Prostatitis symptoms: micturition subscore 1 60 Mean Difference (IV, Fixed, 95% CI) 0.0 [‐1.26, 1.26]
5 Prostatitis symptoms: quality of life subscore 1 60 Mean Difference (IV, Fixed, 95% CI) ‐1.40 [‐2.76, ‐0.04]